UK shares end higher as higher oil puts downbeat mixed output data in the shade
London shares closed firmer on Wednesday as mixed-to-downbeat manufacturing data was counterweighed by upbeat oil prices
Company
LON:FUM
Futura Medical specialises in the development and global commercialisation of innovative sexual health products, including lead product Eroxon®. The company's core strength lies in its research, development and commercialisation of topically delivered gel formulations in sexual health products.
303 stories · page 15 of 16
London shares closed firmer on Wednesday as mixed-to-downbeat manufacturing data was counterweighed by upbeat oil prices
Archive
There has been a change in sentiment towards the pain relief and sexual health products specialist, as news flow has turned positive
David Beckham wants in; Sol Campbell wants out (for a change). There's only one way to settle this, and that's a celebrity EU refendum footie match.
payment processing firm had some long overdue good news, saying first quarter sales were strong and in line with expectations.
"We are very pleased with recent progress in the commercialisation of our product pipeline," chairman John Clarke said
Lekoil nears commercial production in Nigeria; Sound Energy ready to start drilling second well; and Armadale records high graphite grades
The European oil and gas exploration and production company Ascent lived up to its name as resolutions 1 to 3 were duly passed at today’s AGM.
Futura said this Milsing tie-up is in line with strategy of licensing CSD500 to regional distributors in order to build a global distribution network. No financial details were given.
The merger between Aveva Group and Schneider could be back on
TTK Protective Devices, part of the conglomerate TTK Group, will produce the Futura CSD500 prophylactic, which helps men maintain an erection, for distribution worldwide.
The blue chip benchmark closed 1.82% down to 6,053, while the FTSE AIM100 lost 0.17% to 3,357
Already 110 have completed the four-month course of treatment with the other 82 expected to be through the process by the summer.
Investments and investor services
Valentin Bovykin has upped his stake in Obtala above 7%.
Pain relief and sexual health group makes progress with flagship products
Health group expects to have more of a commercial focus in 2016
There is a good chance Kalibrate's petrol station forecourt software will be put through its paces on Wednesday evening after the chancellor of the exchequer's budget speech.
Chancellor of the Exchequer George Osborne gives his budget speech on Wednesday
Futura has been making significant headway with MED2002 and may be in a position to bring in an industry partner next year.
Investments and investor services
Below are the main news-driven share price movements at 4pm.